Fabino Enterprises Ltd vs Gennex Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Fabino Enterprises Ltd is ₹ 20.31 as of 27 Apr 15:30 . The P/E Ratio of Fabino Enterprises Ltd changed from 600 on March 2023 to 84.5 on March 2025 . This represents a CAGR of -47.97% over 3 yearsThe P/E Ratio of Gennex Laboratories Ltd changed from 12.2 on March 2021 to 15.1 on March 2025 . This represents a CAGR of 4.36% over 5 years The Market Cap of Fabino Enterprises Ltd changed from ₹ 6.3 crore on March 2023 to ₹ 5.15 crore on March 2025 . This represents a CAGR of -6.50% over 3 yearsThe Market Cap of Gennex Laboratories Ltd changed from ₹ 49.46 crore on March 2021 to ₹ 274.07 crore on March 2025 . This represents a CAGR of 40.84% over 5 years The revenue of Fabino Enterprises Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Gennex Laboratories Ltd for the Mar '26 is ₹ 62.27 crore as compare to the Dec '25 revenue of ₹ 42.96 crore. This represent the growth of 44.95% The ebitda of Fabino Enterprises Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Gennex Laboratories Ltd for the Mar '26 is ₹ 6.9 crore as compare to the Dec '25 ebitda of ₹ 8.27 crore. This represent the decline of -16.57% The net profit of Fabino Enterprises Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Gennex Laboratories Ltd changed from ₹ 4.66 crore to ₹ 4.46 crore over 8 quarters. This represents a CAGR of -2.17% The Dividend Payout of Fabino Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Gennex Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Fabino Enterprises Ltd

Fabino Enterprises Limited is a growing pharmaceutical company promoted by Atul Kumar Jain.
The Company was incorporated as 'Fabino Life Sciences Private Limited' on October 27, 2011 with the Registrar of Companies, Delhi and Haryana.
Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to 'Fabino Life Sciences Limited'.
A fresh Certificate of Incorporation was issued on March 21, 2015 by the Registrar of Companies, Delhi. The Company operate in the business of manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other consumer products like, packing, trading, etc.
The core business is marketing of pharmaceutical formulation & products in domestic market through its own distribution network and sales force under own brand name, getting Ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc.

About Gennex Laboratories Ltd

Gennex Laboratories Limited, formerly known as Prudential Pharmaceuticals Limited was incorporated on June 25, 1985.
The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is in the business of Manufacturing of Bulk Drugs, Intermediates and Biotech Products.
The Company has over the years added more capacity and infrastructure by way of an additional production block and equipment to the plant to handle more products and tonnages.
The Company is having a professionally managed team at every stage of its operations. Apart from these, Gennex is among the leading Vertically Integrated' pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal.

FAQs for the comparison of Fabino Enterprises Ltd and Gennex Laboratories Ltd

Which company has a larger market capitalization, Fabino Enterprises Ltd or Gennex Laboratories Ltd?

Market cap of Fabino Enterprises Ltd is 4 Cr while Market cap of Gennex Laboratories Ltd is 257 Cr

What are the key factors driving the stock performance of Fabino Enterprises Ltd and Gennex Laboratories Ltd?

The stock performance of Fabino Enterprises Ltd and Gennex Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fabino Enterprises Ltd and Gennex Laboratories Ltd?

As of June 15, 2026, the Fabino Enterprises Ltd stock price is INR ₹20.31. On the other hand, Gennex Laboratories Ltd stock price is INR ₹10.59.

How do dividend payouts of Fabino Enterprises Ltd and Gennex Laboratories Ltd compare?

To compare the dividend payouts of Fabino Enterprises Ltd and Gennex Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.